Status:
WITHDRAWN
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Lead Sponsor:
Mayo Clinic
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
We plan to examine the gastrointestinal (GI) physiologic profile of Exenatide, a glucagon-like peptide (GLP-1) analog as a possible intestino-trophic growth factor capable of inducing small bowel adap...
Eligibility Criteria
Inclusion
- Patients with short bowel syndrome, between the ages of 18-85 who are dependent on parenteral nutrition for at least a year and are being closely followed by the Mayo Clinic Home Parenteral Nutrition Program (HPN) with at least one multisystem evaluation a year.
Exclusion
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01818648
Start Date
March 1 2013
End Date
January 1 2014
Last Update
January 14 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.